A Multicenter, Open-label, Randomized, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib in Combination with Pembrolizumab Versus Treatment of Physician¿s Choice in Participants with Adva
Clinical Trial Grant
Awarded By
Merck Sharp & Dohme
Start Date
May 16, 2018
End Date
December 24, 2024
Awarded By
Merck Sharp & Dohme
Start Date
May 16, 2018
End Date
December 24, 2024